A Clinical Study to Determine Whether an Investigational Medication (SEP-363856) Changes How Long it Takes for Food to Move Through the Stomach Into the Small Intestine in Patients With Schizophrenia. The Study Will Help to Understand Any Effect SEP-363856 May Have on Blood Sugar Levels After a Meal
Condition:   Schizophrenia Interventions:   Drug: SEP-363856;   Drug: Prior antipsychotic (risperidone, olanzapine, quetiapine or aripiprazole) Sponsor:   Sunovion Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 2, 2022 Category: Research Source Type: clinical trials

Study on the Optimal Diagnosis and Treatment Strategy of Major Depressive Disorder Based on Anhedonia
Condition:   Outpatients / Inpatients With Depression Interventions:   Drug: Escitalopram;   Drug: Escitalopram+Aripiprazole;   Drug: Escitalopram+omega-3 PUFAs;   Drug: Escitalopram+Aripiprazole+omega-3 PUFAs Sponsor:   Peking University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 24, 2022 Category: Research Source Type: clinical trials